Zhang et al. further demonstrated that erastin treatment suppresses both mRNA and protein expression of CAPG in HCC, and that ferroptotic stimuli disrupt the binding of HNF4A to the CAPG promoter via KAT2B dissociation 28. The gene discussed is KAT2B; the disease is hepatocellular carcinoma.